BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04165083-completion@plaintrial.com
DTSTAMP:20261029T024152Z
DTSTART;VALUE=DATE:20251031
SUMMARY:KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab
  (MK-3475) When Used With Investigational Agents in Treatment-naïve Parti
 cipants With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Positive
  Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01B/KEYMAKER-U01B) 
 — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04165083
URL:https://plaintrial.com/trial/NCT04165083
END:VEVENT
END:VCALENDAR